Thomas Kipps, MD, PhD, discusses the chronic lymphocytic leukemia treatment spectrum and the explosion of targeted therapies in the field.
Recent Advances in the Treatment of Chronic Lymphocytic Leukemia
Matthew S. Davids, MD, MMSc, discusses the rapid developments in the chronic lymphocytic leukemia treatment landscape.
The treatment spectrum for chronic lymphocytic leukemia has expanded significantly with the development and approval of several new agents.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
3
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
4
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
5
